2023-01-12 | CSE:PREV | Press Release | PreveCeutical Medical Inc
(2023-01-12 | CSE:PREV) PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
Source: stockhouse.com
License Option News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from License Option. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In License Option Today - Breaking & Trending Today
PreveCeutical Medical Inc.: PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2023) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that it has
Source: finanznachrichten.de
Money on the Move: EnPlusOne, Cellarity, Voyager and More
Funding rounds this week saw money flow into innovative drug discovery and delivery platforms, while pharma powerhouse Pfizer wrapped up two high-value neuro deals.
Source: biospace.com
Money on the Move: EnPlusOne, Cellarity, Voyager and More
Funding rounds this week saw money flow into innovative drug discovery and delivery platforms, while pharma powerhouse Pfizer wrapped up two high-value neuro deals.
Source: biospace.com
VOYAGER THERAPEUTICS, INC. : Other Events (form 8-K)
Item 8.01 Other Events. As previously disclosed, on October 1, 2021, Voyager Therapeutics, Inc. entered into an option and license agreement with Pfizer Inc. pursuant to which... | October 4, 2022
Source: marketscreener.com